Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

Guggenheim analyst Vamil Divan lowered the firm’s price target on AbbVie (ABBV) to $212 from $221 and keeps a Buy rating on the shares. The ...

AbbVie (ABBV) continues to dominate the adalimumab market with 72% share in the U.S., despite biosimilar threats gaining ground. Read more here.

In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...

Rita Hayworth, Lucille Ball, Barbra Streisand, Meryl Streep and Julia Roberts are some of the powerful names who have starred ...

View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-host-full-year-and-fourth-quarter-2024-earnings-conference-call ...

NORTH CHICAGO, Ill., Jan. 3, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its full-year and fourth-quarter 2024 financial results on Friday, January 31, 2025, before the market opens.

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable ...

Artificial intelligence tools can fabricate entirely new images and videos. But they can now also make much smaller tweaks by inserting A.I. elements into genuine photographs, further blurring the ...

Here are the best photos of 2024 from the space station. You simply can't beat the views from the International Space Station. So astronauts take hundreds of photos each year. An icy lake in ...

Any commercial use of this content requires a subscription. Click here to find out more. Before you share an image you’ve found on social media, it’s a good idea to first learn more about it, just in ...